From Predicate Devices to Regulatory Intelligence: Reusing Success in Medical Device Development

Medical device innovation rarely starts from scratch. Whether developing the next generation of an existing product, expanding a product family, or entering a new market, manufacturers almost always build upon previous experience. This previous success may be an earlier version of their own device, a legally marketed competitor's device, or accumulated regulatory knowledge from previous projects.

The most successful manufacturers do not simply develop better products—they continuously reuse technical knowledge, regulatory experience, and proven processes. This "predicate mindset" shortens development time, reduces regulatory risks, and allows engineering teams to focus on true innovation instead of recreating existing work.

 

1. Predicate Devices – Learning from Existing Products

 

The concept of a predicate device is well established in the United States and increasingly influences regulatory thinking worldwide.

​

For FDA 510(k) submissions, manufacturers demonstrate substantial equivalence to a legally marketed predicate device. Predicate devices define the regulatory pathway, identify expected performance evidence, and provide valuable insight into previous regulatory decisions.

​

Similarly, China's NMPA classifies products according to product codes and registration pathways. Devices within the same classification generally follow comparable technical requirements, making previous registrations an important source of regulatory intelligence.

​

Manufacturers should therefore study:

• previous FDA 510(k) summaries,

• product classifications,

• technical review guidelines,

• published regulatory decisions,

• and competitor products.

Understanding previous successful registrations is often the fastest way to develop a successful regulatory strategy.

 

2. Every Change Registration Starts with Yesterday's Device

 

For change registrations, the previous device is normally your own product.

The objective is not to rewrite the complete technical documentation but to clearly demonstrate:

• what has changed,

• why it changed,

• whether new risks were introduced,

• and which verification and validation activities demonstrate continued safety and performance.

A structured comparison between generations saves enormous regulatory effort while providing reviewers with a transparent assessment.

Successful manufacturers maintain complete documentation of every product generation so that future registrations become progressively easier.

 

3. Don't Copy Old Documentation—Build Upon It

 

One of the most common mistakes is to update only the sections directly affected by new features.

For example, manufacturers may:

• update only the risk analysis,

• verify only new functions,

• or revise only a few test reports.

This approach is often insufficient for a new medical device generation.

A complete system evaluation should always confirm that the entire device continues to meet safety and performance requirements. Delta testing is appropriate mainly for minor modifications. Even then, a documented change evaluation should explain why previous evidence remains applicable.

Previous documentation provides an excellent starting point—but it should never replace critical engineering judgement.

 

4. Clinical Evidence Also Relies on Previous Experience

 

Predicate thinking extends beyond engineering.

Clinical evaluation frequently relies on equivalent or comparable devices.

Manufacturers collect evidence from:

• published literature,

• post-market surveillance,

• vigilance databases,

• clinical experience,

• and equivalent devices.

Instead of generating unnecessary new clinical data, manufacturers demonstrate that existing knowledge already supports the safety and clinical performance of the device.

This approach is both scientifically sound and consistent with modern regulatory expectations.

 

5. Predicate Thinking Should Apply to Regulatory Affairs Teams

 

The same philosophy should be applied internally.

Every completed regulatory project should become the starting point for the next one.

​

Unfortunately, many companies experience:

• poorly organized document folders,

• undocumented regulatory decisions,

• inconsistent templates,

• loss of project knowledge when employees leave,

• and lengthy onboarding for new regulatory professionals.

Instead, manufacturers should establish a structured regulatory knowledge management system.

 

Each completed registration should include a concise "lessons learned" report describing:

• successful regulatory strategies,

• authority questions,

• deficiency by Notified Body or authority,

• project timelines,

• critical decisions,

• and recommendations for future projects.

 

This enables new employees and future project managers to build upon previous success instead of searching through thousands of documents.

 

Regulatory Intelligence Is More Valuable Than Regulatory Documents

 

Medical device regulations continue to evolve.

New MDR guidance, FDA expectations, NMPA requirements, harmonized standards, and international regulations constantly introduce new challenges.

Regulatory intelligence does not mean starting over with every project.

It means combining:

• previous successful registrations,

• accumulated organizational knowledge,

• evolving regulations,

• and efficient internal processes

to continuously improve registration efficiency and product quality.

​

Conclusion

 

The most successful manufacturers do not reinvent the wheel.

They continuously reuse previous products, previous registrations, previous clinical evidence, previous regulatory experience, and previous project knowledge.

Innovation should focus on what is genuinely new—not on recreating work that has already been successfully completed.

At MedKaizhen, we help manufacturers transform previous regulatory success into future competitive advantage. Beyond supporting global medical device registrations, we promote regulatory intelligence through consulting, e-learning, workshops, and practical project management.

​

Our goal is not only successful market access—but also establishing lean regulatory processes that allow manufacturers, consultants, investors, and universities to continuously build upon previous success.